Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.
Category: Drugs (Pharmaceuticals)
-
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
-
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums
Federal regulators spent billions of dollars to avoid a spike in costs for older Americans that could have been politically damaging to the presidential campaign of Vice President Kamala Harris.
-
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
-
The Global Threat of Antibiotic Resistance
International health experts have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.
-
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
-
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
-
How a Rural Maine County Jail Helped Prisoners Blunt Opioid Cravings
A sheriff fought to give prisoners addicted to opioids a shot that suppresses cravings for a month. Upon release, they were more likely to continue treatment.
-
Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role
More than 150 people were sickened from products sold at smoke and vape shops, providing evidence of the lax regulation of new food items.
-
Dialysis May Prolong Life for Older Patients. But Not by Much.
In one recent study, the challenging regimen added 77 days of life after three years. Often, kidney disease can be managed in other ways.
-
U.S. Unveils Price Limits for 10 Costly or Common Medications
The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
-
2026 Prices for Drugs That Are Subject to Negotiations
The prices were made possible by the Inflation Reduction Act, which granted the health secretary the authority to negotiate on behalf of Medicare.